Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 301 | 94 | 603 | 396 | 521 |
| Receivables | 1,788 | 1,173 | 1,102 | 1,301 | 1,323 |
| TOTAL | $2,206 | $1,460 | $1,934 | $1,921 | $2,130 |
| Non-Current Assets | |||||
| PPE Net | 27 | 30 | 34 | 37 | 41 |
| TOTAL | $27 | $30 | $34 | $37 | $41 |
| Total Assets | $2,233 | $1,490 | $1,968 | $1,958 | $2,171 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,202 | 7,310 | 420 | 355 | 217 |
| Accounts payable and accrued liabilities | 4,524 | 4,183 | 3,749 | 3,619 | 3,198 |
| TOTAL | $13,769 | $11,540 | $4,208 | $4,008 | $3,467 |
| Non-Current Liabilities | |||||
| Long Term Debt | 850 | 875 | 7,592 | 7,647 | 7,471 |
| TOTAL | $850 | $875 | $7,592 | $7,647 | $7,471 |
| Total Liabilities | $14,619 | $12,415 | $11,800 | $11,655 | $10,938 |
| Shareholders' Equity | |||||
| Common Shares | 42,323 | 42,323 | 42,323 | 42,323 | 42,323 |
| Retained earnings | -70,678 | -69,093 | -67,990 | -67,837 | -66,861 |
| Other shareholders' equity | 2,835 | 2,975 | 2,975 | 3,223 | 9,179 |
| TOTAL | $-12,386 | $-10,925 | $-9,831 | $-9,697 | $-8,767 |
| Total Liabilities And Equity | $2,233 | $1,490 | $1,968 | $1,958 | $2,171 |